Friday, 20 Oct 2017

Anti-Rheumatic Rx

Datesort ascending Type Title Save
19 Oct 2017 News Rheumatologists are Slow to Change DMARDs
13 Oct 2017 Social Rheumatology therapeutics market valued at $15billion in 2015, expected to grow to $46bn by 2014. https://t.co/ttBbcKr5Qq
12 Oct 2017 News Novel Gel Drug Delivery Developed for Rheumatoid Arthritis
06 Oct 2017 News 2016 EULAR Guidelines on RA Management
06 Sep 2017 News New EULAR Guidelines for Ultrasound Use
21 Aug 2017 News The Unregulated $37 Billion Supplement Industry
18 Jul 2017 News Curbside Consults - July 2017
22 Jun 2017 News Drug Costs Vary by 600% in Different Countries
21 Jun 2017 Slide of the day ACR/AAHKS Guidelines on Perioperative Management
21 Jun 2017 News ACR/AAHKS Guidelines on Perioperative Management
02 Jun 2017 News 20% Price Hike Among Pfizer Drugs
31 May 2017 Social RT @NYTHealth: Who's to blame for rising drug prices? Not me, says the pharmaceutical industry. https://t.co/tbGnjoVBJX https://t.co/yMMbSL…
20 May 2017 Social My Approach to Difficult RA, some different thoughts/approaches, 7 drugs you've never used and more https://t.co/JvD73ejhwo
11 May 2017 Social Minocycline can be a potential Rx option for Calcinosis related digital ulcers in Scleroderma. https://t.co/8NKQ8RvzS4
11 May 2017 Social CAMERA Study: tis better to add 10mg pred to MTX than not: less Biologic use (30vs50%), less erosions, same safety https://t.co/Lw1WhjMNL1
05 May 2017 Social Dr. Jack Cush at CCR meeting - talking about Difficult RA management. https://t.co/NkW7lj1qbe
04 May 2017 News US Drug Spending Will Rise Steadily Thru 2021
04 May 2017 Social FDA approved oral MTX soln(Xatmet) 2.5mg/ml for poly JIA. Much cheaper to drink parenteral MTX (2.5mg/ml) @same dose https://t.co/T0os9AW4KS
29 Apr 2017 Social RT @DrRachelTate: Dr. Cush's difficult RA equation. @RheumNow #SOTA2017 https://t.co/9GZxxh4WEy
28 Apr 2017 Social NPF Medical Board review says DMARDs (MTX, CyA,TNFi) can be continued perioperatively in Pso/PsA w/ low risk surgery https://t.co/tfNAxO1W9P